Ustekinumab therapy after biologic failure in patients with Crohn's Disease - A real-world single centre experience

被引：0
|
作者：
Majumder, S. [1 ,2 ,3 ]
Bazarova, A. [4 ]
Parigi, T. Lorenzo [1 ,3 ]
Love, M. [5 ]
Davis, J. [3 ]
Ghosh, S. [6 ]
Iacucci, M. [1 ,3 ,7 ,8 ]
Shivaji, U. N. [1 ,3 ,7 ,8 ]
机构：
[1] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England
[2] Univ Birmingham, India Inst, Birmingham, W Midlands, England
[3] Univ Hosp Birmingham NHS Fdn Trust, Gastroenterol, Birmingham, W Midlands, England
[4] Univ Cologne, Biol Phys, Inst Biol Phys, Cologne, Germany
[5] Univ Hosp Birmingham NHS Fdn Trust, Gastroenterol, Birmingham, W Midlands, England
[6] Univ Coll Cork, APC Microbiome, Coll Med & Hlth, Cork, Ireland
[7] Univ Birmingham, Birmingham Biomed Res Ctr, Natl Inst Hlth Res NIHR, Birmingham, W Midlands, England
[8] Univ Hosp Birmingham NHS Fdn Trust, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P699
引用
收藏
页码：832 / 832
页数：1
相关论文
共 50 条
  • [21] Real-World Ustekinumab Experience in Ileum-Dominant Versus Colonic Crohn's Disease
    Vien, Sandy
    Arteaga, Elvis Jovanie
    Grandhe, Sirisha
    Yang, Nuen Tsang
    Mao, Eric J.
    CROHNS & COLITIS 360, 2024, 6 (04)
  • [22] REAL-WORLD EFFECTIVENESS AND SAFETY OF USTEKINUMAB AND VEDOLIZUMAB IN ELDERLY PATIENTS WITH CROHN'S DISEASE
    Garg, Rajat
    Aggarwal, Manik
    Mohammed, Abdul
    Achkar, Jean-Paul
    Lashner, Bret
    Philpott, Jessica
    Cohen, Benjamin L.
    Rieder, Florian
    Qazi, Taha
    Regueiro, Miguel D.
    Click, Benjamin H.
    GASTROENTEROLOGY, 2021, 160 (06) : S560 - S560
  • [23] Ustekinumab induces clinical and biological remission in biologic refractory Crohn's disease patients: A real-world belgian cohort study
    Liefferinckx, C.
    Verstockt, B.
    Gils, A.
    Noman, M.
    Van Kemseke, C.
    Macken, E.
    De Vos, M.
    Van Moerkercke, W.
    Rahier, J. -F.
    Bossuyt, P.
    Dutre, J.
    Humblet, E.
    Staessen, D.
    Peeters, H.
    Van Hootegem, P.
    Louis, E.
    Franchimont, D.
    Baert, F.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S31 - S32
  • [24] Real-World Effectiveness of Ustekinumab Dose Intensification in Crohn's Disease
    Srinivasan, Ashish
    van Langenberg, Daniel
    De Cruz, Peter
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (06) : E69 - E69
  • [25] DISCONTINUATION OF USTEKINUMAB IN PATIENTS WITH CROHN'S DISEASE: MULTI-CENTRE REAL WORLD DATA
    Fenech, Valerie Anne
    Kamperidis, Nikolaos
    Hart, Ailsa
    Thoua, Nora
    Cole, Alexander
    Segal, Jonathan
    Peake, Simon
    Arebi, Naila
    GUT, 2021, 70 : A93 - A94
  • [26] Ustekinumab in Crohn's disease: real-world outcomes and predictors of response
    Lorenzo Gonzalez, Laura
    Valdes Delgado, Teresa
    Vazquez Moron, Juan Maria
    Castro Laria, Luisa
    Leo Carnerero, Eduardo
    Maldonado Perez, Maria Belen
    Sanchez Capilla, Damian
    Pallares Manrique, Hector
    Saez Diaz, Antonia
    Arguelles Arias, Federico
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2022, 114 (05) : 272 - 279
  • [27] Switching from Ustekinumab to Risankizumab Improves Outcomes in Crohn's Disease: A Single-Centre Real-World Data Analysis
    Qazi, U.
    Padley, J.
    Colwill, M.
    Mehta, S.
    Donovan, F.
    Alves, A. M. Francisco
    Pollok, R.
    Poullis, A.
    Patel, K.
    Honap, S.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2012 - i2012
  • [28] REAL WORLD EXPERIENCE WITH USTEKINUMAB IN A PEDIATRIC CROHN'S DISEASE POPULATION
    Du, Lillian
    Ziring, David
    Gonzales, Yvette
    McGovern, Dermot P. B.
    Rabizadeh, Shervin
    GASTROENTEROLOGY, 2020, 158 (06) : S973 - S973
  • [29] Single-centre experience of ustekinumab: Therapeutic drug monitoring in Crohn's disease patients
    Liefferinckx, C.
    Fassin, M.
    Thomas, D.
    Minsart, C.
    Cremer, A.
    Amininejad, L.
    Tafciu, V.
    Wambacq, V.
    Van Gossum, A.
    Franchimont, D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S331 - S333
  • [30] Real-world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort
    Plevris, Nikolas
    Fulforth, James
    Siakavellas, Spyros
    Robertson, Andrew
    Hall, Rebecca
    Tyler, Amy
    Jenkinson, Philip W.
    Campbell, Iona
    Chuah, Cher Shiong
    Kane, Claire
    Veryan, Jennifer
    Lam, Wai Liam
    Saunders, Jayne
    Kelly, Christopher
    Gaya, Daniel
    Jafferbhoy, Hasnain
    Macdonald, Jonathan C.
    Seenan, John Paul
    Mowat, Craig
    Naismith, Graham
    Potts, Lindsay F.
    Sutherland, Diarmid Ian
    Watts, David
    Arnott, Ian
    Bain, Gillian
    Jones, Gareth
    Lees, Charlie W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (08) : 2067 - 2075
12345